These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 39086414)

  • 1. An Overview on Prevalence and Detection Approaches of BRAF V600E Mutation in Anaplastic Thyroid Carcinoma: A Systematic Review and Meta-Analysis.
    Behnagh AK; Eghbali M; Abdolmaleki F; Ghadikolaei OA; Asl PR; Afsharpad M; Cheraghi S; Honardoost M
    Iran J Public Health; 2024 Jul; 53(7):1496-1507. PubMed ID: 39086414
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Histological features of BRAF V600E-mutant anaplastic thyroid carcinoma.
    Chen TY; Lorch JH; Wong KS; Barletta JA
    Histopathology; 2020 Aug; 77(2):314-320. PubMed ID: 32428249
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combination
    Gunda V; Ghosh C; Hu J; Zhang L; Zhang YQ; Shen M; Kebebew E
    Thyroid; 2023 Oct; 33(10):1201-1214. PubMed ID: 37675898
    [No Abstract]   [Full Text] [Related]  

  • 4. Immunohistochemistry as a reliable method for detection of BRAF-V600E mutation in melanoma: a systematic review and meta-analysis of current published literature.
    Anwar MA; Murad F; Dawson E; Abd Elmageed ZY; Tsumagari K; Kandil E
    J Surg Res; 2016 Jun; 203(2):407-15. PubMed ID: 27363650
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diagnostic value of immunohistochemistry for the detection of the BRAF(V600E) mutation in papillary thyroid carcinoma: comparative analysis with three DNA-based assays.
    Ilie MI; Lassalle S; Long-Mira E; Bonnetaud C; Bordone O; Lespinet V; Lamy A; Sabourin JC; Haudebourg J; Butori C; Guevara N; Peyrottes I; Sadoul JL; Bozec A; Santini J; Capper D; von Deimling A; Emile JF; Hofman V; Hofman P
    Thyroid; 2014 May; 24(5):858-66. PubMed ID: 24417277
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeted therapy with vemurafenib in BRAF(V600E)-mutated anaplastic thyroid cancer.
    Lang M; Longerich T; Anamaterou C
    Thyroid Res; 2023 Mar; 16(1):5. PubMed ID: 36855200
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dissecting Anaplastic Thyroid Carcinoma: A Comprehensive Clinical, Histologic, Immunophenotypic, and Molecular Study of 360 Cases.
    Xu B; Fuchs T; Dogan S; Landa I; Katabi N; Fagin JA; Tuttle RM; Sherman E; Gill AJ; Ghossein R
    Thyroid; 2020 Oct; 30(10):1505-1517. PubMed ID: 32284020
    [No Abstract]   [Full Text] [Related]  

  • 8. Complete Surgical Resection Following Neoadjuvant Dabrafenib Plus Trametinib in
    Wang JR; Zafereo ME; Dadu R; Ferrarotto R; Busaidy NL; Lu C; Ahmed S; Gule-Monroe MK; Williams MD; Sturgis EM; Goepfert RP; Gross ND; Lai SY; Gunn GB; Phan J; Rosenthal DI; Fuller CD; Morrison WH; Iyer P; Cabanillas ME
    Thyroid; 2019 Aug; 29(8):1036-1043. PubMed ID: 31319771
    [No Abstract]   [Full Text] [Related]  

  • 9. Activating BRAF and PIK3CA mutations cooperate to promote anaplastic thyroid carcinogenesis.
    Charles RP; Silva J; Iezza G; Phillips WA; McMahon M
    Mol Cancer Res; 2014 Jul; 12(7):979-86. PubMed ID: 24770869
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comprehensive genomic profiling from C-CAT database unveiled over 80% presence of oncogenic drivers in anaplastic thyroid carcinoma including BRAF, RAS family, NF1, and FGFR1.
    Saito Y; Kage H; Kobayashi K; Kamogashira T; Fukuoka O; Yamamura K; Yamashita S; Tanabe M; Oda K; Kondo K
    Clin Endocrinol (Oxf); 2024 Aug; 101(2):170-179. PubMed ID: 38853441
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Specific immunohistochemical detection of the BRAF V600E mutation in primary and metastatic papillary thyroid carcinoma.
    Zhu X; Luo Y; Bai Q; Lu Y; Lu Y; Wu L; Zhou X
    Exp Mol Pathol; 2016 Feb; 100(1):236-41. PubMed ID: 26795218
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Investigation of BRAF V600E detection approaches in papillary thyroid carcinoma.
    Chen D; Qi W; Zhang P; Zhang Y; Liu Y; Guan H; Wang L
    Pathol Res Pract; 2018 Feb; 214(2):303-307. PubMed ID: 29254799
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnostic value of fine needle aspiration BRAF(V600E) mutation analysis in papillary thyroid cancer: a systematic review and meta-analysis.
    Fnais N; Soobiah C; Al-Qahtani K; Hamid JS; Perrier L; Straus SE; Tricco AC
    Hum Pathol; 2015 Oct; 46(10):1443-54. PubMed ID: 26232865
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunohistochemistry is highly sensitive and specific for detecting the BRAF V600E mutation in papillary thyroid carcinoma.
    Sun J; Zhang J; Lu J; Gao J; Lu T; Ren X; Duan H; Liang Z
    Int J Clin Exp Pathol; 2015; 8(11):15072-8. PubMed ID: 26823846
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An affordable immunohistochemical approach to estimate the prevalence of
    Choden S; Keelawat S; Jung CK; Bychkov A
    Gland Surg; 2020 Oct; 9(5):1867-1877. PubMed ID: 33224862
    [TBL] [Abstract][Full Text] [Related]  

  • 16. VE1 immunohistochemistry is an adjunct tool for detection of BRAF
    Rashid FA; Tabassum S; Khan MS; Ansari HR; Asif M; Sheikh AK; Sameer Aga S
    J Clin Lab Anal; 2021 Feb; 35(2):e23628. PubMed ID: 33305405
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical utility of immunohistochemistry for the detection of the BRAF v600e mutation in papillary thyroid carcinoma.
    Zagzag J; Pollack A; Dultz L; Dhar S; Ogilvie JB; Heller KS; Deng FM; Patel KN
    Surgery; 2013 Dec; 154(6):1199-204; discussion 1204-5. PubMed ID: 23931769
    [TBL] [Abstract][Full Text] [Related]  

  • 18.
    Mamat Yusof MN; Ch'ng ES; Radhiah Abdul Rahman N
    Cancers (Basel); 2022 Nov; 14(22):. PubMed ID: 36428683
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mutation based approaches to the treatment of anaplastic thyroid cancer.
    McCrary HC; Aoki J; Huang Y; Chadwick B; Kerrigan K; Witt B; Hunt JP; Abraham D
    Clin Endocrinol (Oxf); 2022 May; 96(5):734-742. PubMed ID: 35067961
    [TBL] [Abstract][Full Text] [Related]  

  • 20. BRAF
    Kaabouch M; Chahdi H; Azouzi N; Oukabli M; Rharrassi I; Boudhas A; Jaddi H; Ababou M; Dakka N; Boichard A; Bakri Y; Dupuy C; Al Bouzidi A; El Hassani RA
    Afr Health Sci; 2020 Dec; 20(4):1849-1856. PubMed ID: 34394248
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.